5-硝基噻酚-2-甲腈 | 16689-02-4

• 物质功能分类: 医药中间体 - 杂环化合物 - 噻吩类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 噻吩类
• 中文名称: 5-硝基噻酚-2-甲腈
• 中文别名: 5-硝基-2-噻吩甲腈；2-氰基-5-硝基噻吩；5-硝基噻吩-2-甲腈
• 英文名称: 5-nitro-2-thienyl cyanide
• 英文别名: 5-nitro-thiophene-2-carbonitrile；2-cyano-5-nitrothiophene；5-Nitrothiophene-2-carbonitrile
• CAS: 16689-02-4
• 化学式: C₅H₂N₂O₂S
• mdl: MFCD00052401
• 分子量: 154.149
• InChiKey: FLYONFCGDKAMIH-UHFFFAOYSA-N

物化性质

• 熔点：
  42-46 °C
• 沸点：
  273.9±25.0 °C(Predicted)
• 密度：
  1.50±0.1 g/cm3(Predicted)
• 稳定性/保质期：
  常温常压下稳定，应避免接触氧化物。

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  10
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  97.8
• 氢给体数：
  0
• 氢受体数：
  4

安全信息

• 危险等级：
  6.1
• 危险品标志：
  Xn
• 安全说明：
  S22,S36/37
• 危险类别码：
  R20/21/22
• WGK Germany：
  3
• 海关编码：
  2934999090
• 危险品运输编号：
  UN 3439 6.1/PG 3
• 危险类别：
  6.1
• 包装等级：
  III
• 危险性防范说明：
  P280,P310,P305+P351+P338
• 危险性描述：
  H302,H312,H319,H332
• 储存条件：
  常温下应密闭避光保存，并保持通风和干燥。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 5-Nitrothiophene-2-carbonitrile
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H331: Toxic if inhaled
H302: Harmful if swallowed
H312: Harmful in contact with skin
Causes skin irritation
H315:
H319: Causes serious eye irritation
H335: May cause respiratory irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
P280: Wear protective gloves/protective clothing/eye protection/face protection
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P304+P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing
P405: Store locked up

---

Section 3. Composition/information on ingredients.
Ingredient name: 5-Nitrothiophene-2-carbonitrile
CAS number: 16689-02-4

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
Eye contact:
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels, refrigerated.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C5H2N2O2S
Molecular weight: 154.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, sulfur oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
UN Number: UN3439 Class: 6.1 Packing group: III
Proper shipping name: NITRILES, TOXIC, SOLID, N.O.S. (5-Nitrothiophene-2-carbonitrile)

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  5-硝基噻酚-2-甲腈 在 potassium fluoride 、 四苯基溴化膦 、 邻苯二甲酰氯 作用下， 以 环丁砜 为溶剂， 反应 2.0h， 以76%的产率得到5-氟噻吩-2-甲腈
  参考文献：
  名称：

  INHIBITOR OF CASEIN KINASE 1DELTA AND CASEIN KINASE 1E

  摘要：

  提供了一种新型的噁唑酮衍生物，具有对酪蛋白激酶1δ和酪蛋白激酶1ε的抑制活性。此外，该抑制剂还能抑制酪蛋白激酶1δ和酪蛋白激酶1ε，因此还提供了一种用于治疗和/或预防与酪蛋白激酶1δ或酪蛋白激酶1ε的激活机制相关的疾病的药物剂。此外，还提供了一种用于治疗尤其是昼夜节律紊乱（包括睡眠障碍）、中枢神经退行性疾病和癌症的药物剂。一种酪蛋白激酶1δ和酪蛋白激酶1ε的抑制剂，包括作为活性成分的噁唑酮衍生物，其表示如下通用式（1），其盐、溶剂或水合物：其中X代表卤素原子（可以是氟原子、氯原子、溴原子或碘原子中的任意一种）。

  公开号：

  US20130137730A1
• 作为产物：
  描述：

  5-硝基噻吩-2-甲醛 在 吡啶 、 盐酸羟胺 、 乙酸酐 作用下， 以 吡啶 为溶剂， 反应 1.0h， 生成 5-硝基噻酚-2-甲腈
  参考文献：
  名称：

  共轭长度与在非线性光学η电荷转移之间折衷5的合成，电化学研究和第一超极化：-monocyclopentadienyliron（II）配合物与取代的低聚噻吩腈配位体

  摘要：

  一个系统的一系列的η 5通式-monocyclopentadienyliron（II）配合物与取代的低聚噻吩腈配体[FeCp（P_P）（NC {SC 4 ħ 2 } Ñ NO 2）] [PF 6 ]（P_P = DPPE，（ +）-diop；n  = 1-3）已合成并表征。通过循环伏安法研究了新化合物的电化学行为。已经通过在1.064和1.550μm的两个基本波长下的超瑞利散射（HRS）测量来确定具有dppe大分子配体的二次超极化率（β），以揭示双光子共振效应并估计静态β价值观。将所得到的总的结果被发现是比用于相关η更好5 -monocyclopentadienyliron（II）络合物与p -苄腈衍生物。虽然增加了谐振的β在1.064微米与在共轭配体增加的噻吩单元的数目被发现（高达910×10 -30  ESU），静态值β 0保持几乎不变，如图中的1.550微米测量。结合电化学和光谱数据

  DOI：

  10.1016/j.jorganchem.2007.03.023
• 作为试剂：
  描述：

  2-氰基噻吩 、 硝酸 在 ice water 、 5-硝基噻酚-2-甲腈 作用下， 以 硫酸 为溶剂， 生成 2-Cyano-5-nitro-thiophene 2-cyano-4-nitro-thiophene
  参考文献：
  名称：

  Hydroxybenzylamino derivatives as anti-inflammatory agents

  摘要：

  羟基苯甲醛和胺经过还原反应，制备出羟基苯甲酰胺衍生物。这些化合物被发现具有活性的局部抗炎作用。

  公开号：

  US04578390A1

文献信息

• Vicarious nucleophilic substitution of hydrogen in nitroderivatives of five-membered heteroaromatic compounds
  作者：Mieczyslaw Makosza、Ewa Kwast

  DOI：10.1016/0040-4020(95)00445-e

  日期：1995.7

  Nitro derivatives of thiophene, furan and pyrrole react with carbanions containing leaving groups giving products of replacement of hydrogen with functionalized alkyl substituents. Many specific features of this reaction are discussed.

  噻吩，呋喃和吡咯的硝基衍生物与含有离去基团的碳负离子反应，生成被官能化的烷基取代基取代氢的产物。讨论了该反应的许多具体特征。
• [EN] MODIFIED PROTEINS AND PROTEIN DEGRADERS<br/>[FR] PROTÉINES MODIFIÉES ET AGENTS DE DÉGRADATION DE PROTÉINES
  申请人：CULLGEN SHANGHAI INC

  公开号：WO2021239117A1

  公开（公告）日：2021-12-02

  Provided herein are compounds, pharmaceutical compositions, and methods for binding or degrading target proteins. Further provided herein are compounds having a DNA damage-binding protein 1 (DDB1) binding moiety. Some such embodiments include a linker. Some such embodiments include a target protein binding moiety. Further provided herein are ligand-DDB1 complexes. Further provided herein are in vivo modified DDB1 proteins.

  本文提供了结合或降解靶蛋白的化合物、药物组合物和方法。本文还提供了具有DNA损伤结合蛋白1（DDB1）结合基团的化合物。其中一些实施例包括连接物。其中一些实施例包括靶蛋白结合基团。本文还提供了配体-DDB1复合物。本文还提供了体内修饰的DDB1蛋白。
• Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
  申请人：Bayer Corporation

  公开号：US06353006B1

  公开（公告）日：2002-03-05

  This invention relates to 2-arylimino heterocycles, including 2-arylimino-1,3-thiazolidines, 2-arylimino-2,3,4,5-tetrahydro-1,3-thiazines, 2-arylimino-1,3-thiazolidin-4-ones, 2-arylimino-1,3-thiazolidin-5-ones, and 2-arylimino-1,3-oxazolidines, and their use in modulating progesterone receptor mediated processes, and pharmaceutical compositions for use in such therapies.

  这项发明涉及2-芳基亚胺杂环化合物，包括2-芳基亚胺-1,3-噻唑啉、2-芳基亚胺-2,3,4,5-四氢-1,3-噻嗪、2-芳基亚胺-1,3-噻唑啉-4-酮、2-芳基亚胺-1,3-噻唑啉-5-酮和2-芳基亚胺-1,3-噁唑啉，以及它们在调节孕激素受体介导的过程中的应用，以及用于这类治疗的药物组合物。
• Cascade Process for Direct Transformation of Aldehydes (RCHO) to Nitriles (RCN) Using Inorganic Reagents NH₂OH/Na₂CO₃/SO₂F₂ in DMSO
  作者：Wan-Yin Fang、Hua-Li Qin

  DOI：10.1021/acs.joc.8b03164

  日期：2019.5.3

  and practical process for direct conversion of aldehydes to nitriles was developed feathering a wide substrate scope and great functional group tolerability (52 examples, over 90% yield in most cases) using inorganic reagents (NH2OH/Na2CO3/SO2F2) in DMSO. This method allows for transformations of readily available, inexpensive, and abundant aldehydes to highly valuable nitriles in a pot, atom, and

  使用无机试剂（NH 2 OH / Na 2 CO ）开发了一种简单，温和且实用的方法，将醛直接转化为腈，可在较宽的底物范围内实现出色的官能团耐受性（52个实例，大多数情况下产率超过90％）3 / SO 2 F 2）在DMSO中。该方法允许以易用，原子和步经济的方式将易于获得，廉价且丰富的醛转化为高度有价值的腈，而无需过渡金属。该协议将作为将氰基部分安装到复杂分子的强大工具。
• SPIROINDOLINONE PYRROLIDINES
  申请人：Bartkovitz David Joseph

  公开号：US20110130398A1

  公开（公告）日：2011-06-02

  There are provided compounds of the formula wherein X, Y and R 1 to R 8 are described herein along with the enantiomers, pharmaceutically acceptable salts and esters thereof. The compounds are useful as anticancer agents.

  提供了以下式中的化合物，其中X、Y和R1至R8如本文所述，以及其对映体、药用可接受的盐和酯。这些化合物可用作抗癌药物。

表征谱图